Stock Analysis of ADMA Biologics Inc (ADMA) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ADMA
Close 9.06
Change -0.0400 / 0.440 %
Volume 2114.34 K
Vol Change -1014.61 K / 32.43 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bullish
Growth Index Low Growth Stock
Value Index Poor Value Stock
Profitability Index No Significant Profitability
Stability Index Very Low Stability Stock


Fundamental View of ADMA Biologics Inc
PE (TTM)

-572.29

Very Poor
Price / Book

14.23

Very Poor
Price / Sales

7.36

Very Poor
Piotroski F Score

3.0

Not Good
Market Cap

2100.19 M

Enterprise Value

2180.48 M

ROA (TTM)

-1.06

Very Poor
ROE (TTM)

-2.49

Very Poor
Net Margin (TTM)

-1.29

Very Poor
Revenue

52.06 %

234292 K
Net Profit

73.20 %

-22826.15 K
Debt to Equity

0.974

Good
Altman Z Score

5.83

Excellent
Quick Ratio

1.69

Indecisive
Cash Ratio

1.03

Indecisive


Highs/Lows of ADMA Biologics Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week6.93 30.74 % 1.59 % 9.337.9615-May-2410-May-24
Two Week6.74 34.42 % 4.60 % 9.336.6515-May-2403-May-24
One Month6.16 47.08 % 4.86 % 9.335.9715-May-2417-Apr-24
Three Month5.28 71.59 % 5.82 % 9.335.0215-May-2421-Feb-24
Six Months3.81 137.80 % 17.50 % 9.333.615-May-2412-Dec-23
One year4.08 122.06 % 28.89 % 9.333.0615-May-2423-Oct-23
Two year1.87 384.49 % 32.16 % 9.332.2415-May-2429-Sep-22
Five year4.22 114.69 % 84.16 % 9.331.0115-May-2421-Oct-21
Ten year7.5 20.80 % 182.08 % 14.01.0103-Dec-1421-Oct-21


Technical View of ADMA Biologics Inc
RSI

85.06

Mild Bearish
MACD

0.705

Bullish
ADX

41.93

Bullish
Super Trend

8.04

Mild Bullish
Williams %R

-9.51

Mild Bearish
CCI

145.04

Bearish


EMA 5

8.75

Bullish
EMA 15

7.80

Bullish
EMA 50

6.74

Strong Bullish
EMA 100

6.02

Strong Bullish
SMA 100

5.87

Strong Bullish
SMA 200

4.81

Strong Bullish
SMA 5 / 20

8.98 / 7.22

Strong Bullish
SMA 15 / 50

7.49 / 6.63

Strong Bullish
SMA 50 / 200

6.63 / 4.81

Strong Bullish




Charts of ADMA Biologics Inc


Returns of ADMA Biologics Inc with Peers
Period / StockADMARCKTNVAXSTAA
1 Week30.74%0.300%222.15%-0.560%
1 Mth47.08%-3.51%260.90%-8.58%
3 Mth71.59%-22.03%246.15%38.15%
6mth137.80%9.60%147.00%20.87%
1 Year122.06%9.40%88.48%-31.07%
2 Year384.49%158.28%-70.00%-22.85%
5 Years114.69%32.88%123.95%70.48%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of ADMA Biologics Inc with Peers
Ratio / StockADMARCKTNVAXSTAA
PE-572.29-3861.78-4.21208.65
P/B14.232087.91-2.145.38
ROA-1.06-47.84-24.812.07
ROE-2.49-54.0702.58
Debt To Equity0.9740.0055-0.2420.0113
Revenue234292 K
52.06 % 		0
% 		983705 K
50.36 % 		322415
99.89 %
Net Income-22826.15 K
73.20 % 		-252658.00 K
13.88 % 		-545062.00 K
17.16 % 		21347.00
99.94 %


Technicals of ADMA Biologics Inc with Peers
Technical / StockADMARCKTNVAXSTAA-
ADX41.9313.9035.8323.64
CMF0.392-0.265-0.094-0.155
MFI86.3453.9491.2155.82
RSI85.0647.8488.8844.34
MACD Abv SignalTrueTrueTrueFalse
Price Above 50 MATrueFalseTrueFalse-
Price Above 200 MATrueTrueTrueTrue-


About : ADMA Biologics Inc

Address : 465 State Route 17, Ramsey, NJ, United States, 07446
Tel : 201 478 5552
URL : https://www.admabiologics.com
Code : ADMA, ISIN : US0008991046, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 17_Oct_2013
Employee Count : 624

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.


Note : All Data Generated at the End of Trading Hours (EOD Data)